Rangers Pharmaceutical A/S: Financial statements 2025
CVR: 40381015
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092. The solvency ratio was 34.4%.
- Gross Profit
- DKK -265,330
- Profit/Loss
- DKK -265,257
- Equity
- DKK 101,092
- Total Assets
- DKK 293,534
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -265K | -265K | 101K | 0 |
| 2024 | - | -90K | 1.6M | -50.8M | - |
| 2023 | - | -232K | 1.2M | -52.4M | - |
| 2022 | - | -1.1M | -53.1M | -53.6M | - |
| 2021 | - | -2.7M | -2.7M | -533K | 0 |
Official annual report
How creditworthy is Rangers Pharmaceutical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 25, 2025, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.
As of November 25, 2025, Niels Løber is registered as liquidator of Rangers Pharmaceutical A/S.
As of November 25, 2025, Clifford Starke has stepped down as adm. dir. of Rangers Pharmaceutical A/S.
On November 25, 2025, Rangers Pharmaceutical A/S entered liquidation.
As of September 26, 2025, Dany Vaiman has left the board of directors of Rangers Pharmaceutical A/S.
As of September 26, 2025, Michael James Rank has left the board of directors of Rangers Pharmaceutical A/S.
Rangers Pharmaceutical A/S has published its annual report for 2024. Gross profit came to DKK -90,401, and the net result was DKK 1,641,287.
About Rangers Pharmaceutical A/S
Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.
